Get started
Author

Celine J. Marmion

Observed names: C. J. Marmion, C.J. Marmion, Celine J Marmion, Celine Marmion, Celine J. Marmion, Marmion, C., Marmion, C.J., Marmion, Celine J.
ORCID: 0000-0003-0637-6693
Observed ORCID: 0000-0003-0637-6693
OpenAlex ID: A5049833090
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 · Reece G. Kenny, Celine J. Marmion · Chemical Reviews · 643
Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands
2004 · Celine J. Marmion, Darren Griffith, et al. · European Journal of Inorganic Chemistry · 182
Platinum(IV) Prodrugs – A Step Closer to Ehrlich's Vision?
2016 · Reece G. Kenny, Su Wen Chuah, et al. · European Journal of Inorganic Chemistry · 167
Copper complexes as artificial DNA metallonucleases: From Sigman’s reagent to next generation anti-cancer agent?
2017 · T.J.P. McGivern, S. Afsharpour, et al. · Inorganica Chimica Acta · 130
A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
2009 · Darren Griffith, Maria P. Morgan, et al. · Chemical Communications · 109
PDF
Suberoylanilide hydroxamic acid, a potent histone deacetylase inhibitor; its X-ray crystal structure and solid state and solution studies of its Zn(II), Ni(II), Cu(II) and Fe(III) complexes
2011 · Darren M. Griffith, Béla Szőcs, et al. · Journal of Inorganic Biochemistry · 81
A novel dual-functioning ruthenium(II)–arene complex of an anti-microbial ciprofloxacin derivative — Anti-proliferative and anti-microbial activity
2016 · Ziga Ude, Isolda Romero-Canelón, et al. · Journal of Inorganic Biochemistry · 69
PDF
Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer
2015 · James P. Parker, Ziga Ude, et al. · Metallomics · 58
Hydroxamic acids are nitric oxide donors. Facile formation of ruthenium(II)-nitrosyls and NO-mediated activation of guanylate cyclase by hydroxamic acids
2000 · Celine J. Marmion, Terry Murphy, et al. · Chemical Communications · 58
Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
2010 · Darren Griffith, James P. Parker, et al. · Anti-Cancer Agents in Medicinal Chemistry · 53
Valuable Insight into the Anticancer Activity of the Platinum-Histone Deacetylase Inhibitor Conjugate, cis-[Pt(NH3)2malSAHA–2H)]
2012 · Viktor Brabec, Darren M. Griffith, et al. · Molecular Pharmaceutics · 46
Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity
2011 · Darren M. Griffith, Brian Duff, et al. · Journal of Inorganic Biochemistry · 45
Ruthenium(III) dimethyl sulfoxide pyridinehydroxamic acid complexes as potential antimetastatic agents: synthesis, characterisation and in vitro pharmacological evaluation
2008 · Darren Griffith, Sara Cecco, et al. · JBIC Journal of Biological Inorganic Chemistry · 40
New tetradentate Schiff bases, their oxovanadium(IV) complexes, and some complexes of bidentate Schiff bases with vanadium(III)
1997 · Nosheen Choudhary, David L. Hughes, et al. · Polyhedron · 36
Ruthenium as an Effective Nitric Oxide Scavenger
2004 · Celine J. Marmion, Beth Cameron, et al. · Current Topics in Medicinal Chemistry · 35
A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity
2013 · James P. Parker, Hassan Nimir, et al. · Journal of Inorganic Biochemistry · 34
PDF
Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors
2019 · Reece G. Kenny, Ziga Ude, et al. · Journal of Inorganic Biochemistry · 33
Monohydroxamic acids and bridging dihydroxamic acids as chelators to ruthenium( iii ) and as nitric oxide donors: syntheses, speciation studies and nitric oxide releasing investigation
2007 · Darren Griffith, Krystyna Krot, et al. · Dalton Transactions · 33
Novel platinum(ii) ammine hydroxamate and hydroximate complexes and the platinum-assisted hydrolysis of hydroxamic acids
2005 · Darren Griffith, Konstantin Lyssenko, et al. · Dalton Transactions · 29
Innovative DNA-Targeted Metallo-prodrug Strategy Combining Histone Deacetylase Inhibition with Oxidative Stress
2018 · Tadhg J. P. McGivern, Creina Slator, et al. · Molecular Pharmaceutics · 28
A new class of prophylactic metallo-antibiotic possessing potent anti-cancer and anti-microbial properties
2019 · Ziga Ude, Kevin Kavanagh, et al. · Dalton Transactions · 26
PDF
Novel palladium(II) and platinum(II) complexes of biocidal benzisothiazolinone (Bit); X-ray crystal structures of co-crystallised Bit/BitO and cis-Pd(en)(Bit−1H)2·H2O
2010 · Darren M. Griffith, Aisleen Haughey, et al. · Inorganica Chimica Acta · 23
Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties
2007 · Darren Griffith, Alberta Bergamo, et al. · Polyhedron · 23
Synthesis, characterisation and speciation studies of heterobimetallic pyridinehydroxamate-bridged Pt(ii)/M(ii) complexes (M = Cu, Ni, Zn). Crystal structure of a novel heterobimetallic 3-pyridinehydroxamate-bridged Pt(ii)/Cu(ii) wave-like coordination polymer
2005 · Clodagh Mulcahy, Fedor M. Dolgushin, et al. · Dalton Transactions · 21
Ruthenium(iii) readily abstracts NO from l-arginine, the physiological precursor to NO, in the presence of H2O2. A remarkably simple model system for NO synthases
2001 · Celine J. Marmion, Terry Murphy, et al. · Chemical Communications · 19
Works count: 74
Citation count: 2,183
H-index: 23
I10-index: 33
Year
Topic
Type